Hi Ajostu. Unfortunately I can’t make it to the AGM…but I would love to know:
-Neuren has regularly stated they understand the extent of resources required to ensure trofinetide is commercialised as quickly as possible. Does Neuren favour a licensing approach or would an outright sale of Neuren also be considered?
-What has Leerink been instructed to undertake?
-Current cash projects show Neuren will need cash by the end of the year. Is it expected that a deal will be done before a more typical capital raise is required?
-Is Neuren intending to fill the role vacated by Joe Horrigan?
-Did Neuren apply for Breakthrough Therapy Status for Fragile X?
-Has Neuren imposed any social media restrictions on participants in the Rett Phase 2b trial?
-What is the next step for NNZ – 2591 and when will that occur?
- Forums
- ASX - By Stock
- AGM questions
Hi Ajostu. Unfortunately I can’t make it to the AGM…but I would...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.97 |
Change
0.070(0.35%) |
Mkt cap ! $2.552B |
Open | High | Low | Value | Volume |
$20.22 | $20.44 | $19.85 | $4.194M | 209.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2772 | $19.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.99 | 3310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 441 | 19.840 |
1 | 979 | 19.830 |
1 | 26 | 19.810 |
3 | 1278 | 19.800 |
2 | 4391 | 19.790 |
Price($) | Vol. | No. |
---|---|---|
20.000 | 150 | 1 |
20.030 | 441 | 2 |
20.050 | 1010 | 2 |
20.090 | 979 | 1 |
20.100 | 157 | 2 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |